Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Abeona Therapeutics Inc. (ABEO) Stock · SELL · CRISIS | LOPJLB

Abeona Therapeutics Inc. (ABEO)

Healthcare

$4.52-7.76%Close

SELLCRISIS · day 12

ABEO▼ SELL

$4.52-7.76%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Market cap: $258M

1W: -9.78%
1M: -16.76%

vs SPY 1W: -9.64%
vs SPY 1M: -19.26%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Sector: Healthcare

Company news

globenewswire.com · 7d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

globenewswire.com · 12d ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

prnewswire.com · 13d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

globenewswire.com · 14d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

prnewswire.com · 19d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

globenewswire.com · 21d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

marketbeat.com · 21d ago

Abeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. Wainwright

marketbeat.com · 22d ago

Abeona Expands ZEVASKYN Network as RDEB Launch Gains Momentum

benzinga.com · 26d ago

Abeona Stands to Collect Royalties After Ultragenyx's FDA Approval — Here's the Rest of the Week

globenewswire.com · 26d ago

Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)

prnewswire.com · 27d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

seekingalpha.com · 28d ago

Abeona Therapeutics Inc. (ABEO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

globenewswire.com · 28d ago

Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®

globenewswire.com · 29d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

prnewswire.com · 34d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

businesswire.com · 35d ago

ABEO Investors Have Opportunity to Join Abeona Therapeutics Inc. Fraud Investigation with SBS Law

gurufocus.com · 35d ago

ABEO Investors Have Opportunity to Join Abeona Therapeutics Inc. Fraud Investigation with SBS Law

globenewswire.com · 35d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

prnewswire.com · 41d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

globenewswire.com · 42d ago

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Market news & ticker search · RSS for ABEO

FAQ

What is LOPJLB’s current signal on ABEO?: LOPJLB’s latest quantitative signal on Abeona Therapeutics Inc. (ABEO) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is ABEO in?: Abeona Therapeutics Inc. (ABEO) is currently classified in the CRISIS HMM market regime on LOPJLB.

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Docs Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener Best dividend stocks Undervalued stocks Best S&P 500 stocks

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE🔒COIL

Congress trades

STOCK Act filings · … on file

Full congress tracker →

Loading disclosures…